PsyMed Ventures Newsletter

Share this post

DMTweet: a psychedelic tweet recap

psymedventures.substack.com

DMTweet: a psychedelic tweet recap

a PsyMed Ventures x Business Trip collab

PsyMed Ventures
Jan 23, 2022
1
Share this post

DMTweet: a psychedelic tweet recap

psymedventures.substack.com

DMTweet is a newsletter of psychedelic tweets that catch our eye 👀.

This is a collaboration between PsyMed Ventures and Business Trip (yes, we’re the folks working on both 🙃).

Tweets include: Industry updates 💼, Therapy 🛋️, Psychedelic research 🧪, Neuroscience 🧠, Consciousness ✨, Indigenous reciprocity ⚖️, Regulatory updates 📜, and Trippy ideas 👽.

Inclusion = interesting ≠ endorsements.

Let’s get to it….

Twitter avatar for @MichaelHaichin
Michael Haichin @MichaelHaichin
NIH Psychedelic workshop was pretty great. Suggest watching the recordings whenever they are released. Sharing some highlights below 1/
5:48 AM ∙ Jan 14, 2022
52Likes9Retweets

(↑ click to see thread ↑)

Twitter avatar for @jesse_yeji
Yeji Jesse Lee 이예지 @jesse_yeji
Big Pharma firm Otsuka makes another investment into psychedelics. The co's McQuade Center is investing $5 million in @MindsetPharma to develop two psychedelic compounds through phase I trials Otsuka invested in @COMPASSPathway' series B round in 2020.
bloomberg.comBloomberg - Are you a robot?
4:34 PM ∙ Jan 5, 2022
13Likes3Retweets
Twitter avatar for @HamiltonMorris
@hamiltonmorris @HamiltonMorris
The DEA have announced their intention to place five tryptamine psychedelics in schedule I on February 14. Despite apparent progress, the gears of prohibition continue to grind away at personal and scientific freedom. federalregister.gov/documents/2022…
12:14 AM ∙ Jan 20, 2022
1,164Likes587Retweets
Twitter avatar for @ReillyCapps
Reilly Capps @ReillyCapps
scientific paper analyzed bad trip reports. "distortions at the level of thought were the main cause for bad trips" guides say: "come back to the body, to the senses."
journals.plos.orgSelf-reported negative outcomes of psilocybin users: A quantitative textual analysisPsilocybin, a substance mainly found in mushrooms of the genus psilocybe, has been historically used for ritualistic, recreational and, more recently, medicinal purposes. The scientific literature suggests low toxicity, low risk of addiction, overdose, or other causes of injury commonly caused by su…
4:59 AM ∙ Jan 20, 2022
21Likes2Retweets
Twitter avatar for @DEOlsonLab
Olson Lab @DEOlsonLab
We have found the same thing when administering psychedelics! We recommend that experimenter sex be reported in methods sections.
Twitter avatar for @zenbrainest
BryanRoth @zenbrainest
'We found that mice manifest aversion to human male odours, preference to female odours, and increased susceptibility to stress when handled by male experimenters.' https://t.co/CyxIvpa76g
2:46 PM ∙ Jan 13, 2022
30Likes5Retweets
Twitter avatar for @SeriouslySamuel
SamChapman.eth @SeriouslySamuel
Dear Psychedelic Community, Can we please replace the valuation statements of how much the “market” is going to be worth by X year, and instead highlight the number of people that stand to benefit from accessing safe and legal psychedelic services? k, thx bye
5:20 PM ∙ Jan 21, 2022
69Likes6Retweets
Twitter avatar for @QiaochuYuan
QC @QiaochuYuan
thread of therapy and therapy-like thingies that have helped me or people i know:
8:36 PM ∙ Jan 10, 2022
390Likes55Retweets
Twitter avatar for @dremilyanhalt
Dr. Emily Anhalt @dremilyanhalt
There is a whole lot of Live Laugh Love pop-psychology bullsh*t out there. Time to bust some myths 🧵👇
10:04 PM ∙ Jan 18, 2022
809Likes255Retweets
Twitter avatar for @JacobSAday
Jacob S. Aday, Ph.D. @JacobSAday
I feel like a biopic or even series on Timothy Leary would kill—his life story is insane
9:28 PM ∙ Jan 14, 2022
24Likes1Retweet
Twitter avatar for @zackamenetz
Zac Kamenetz @zackamenetz
Tell me you live in Berkeley without telling me you live in Berkeley
Image
12:23 AM ∙ Jan 13, 2022
Twitter avatar for @Disruptepreneur
Jeremy Gardner @Disruptepreneur
Just received the initial green light from a group of foremost neuroscientists and researchers at a top university to develop a study and set of experiments based on a hypothesis and test I conceived of while blasted off on DMT.
5:48 PM ∙ Jan 19, 2022

Until next time…

Greg, Matias, and Dina

🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄

Subscribe to DMTweet to receive our next tweet newsletter.

🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄

DMTweet is a collab between PsyMed Ventures and Business Trip. PsyMed Ventures is a community-focused fund and syndicate investing in psychedelic medicine and mental health tech. Business Trip is a podcast about psychedelic entrepreneurship. Our mission is to help expand access to psychedelic medicine and mental health.

Twitter avatar for @crunchbasenews
Crunchbase News @crunchbasenews
PsyMed Ventures founders tell us the new $25M fund will invest in early-stage startups, primarily those working on psychedelics, as well as startups working on neurotechnology, digital health and precision psychology to help treat mental ailments. news.crunchbase.com/news/psymed-ve…
Image
7:05 PM ∙ Jan 7, 2022
4Likes1Retweet
Share this post

DMTweet: a psychedelic tweet recap

psymedventures.substack.com
Comments
TopNewCommunity

No posts

Ready for more?

© 2023 Business Trip
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing